Validating genomic tools for precision medicine in CLL: ERIC leads the way

por Wiestner, Adrian
Publicado 2021

Pathogenesis of CLL: the view from the lymph node

por Wiestner, Adrian
Publicado 2018

Beyond SARS-CoV2, the role of viruses in the pathogenesis of hematologic malignancies

por Wiestner, Adrian
Publicado 2022

CLL kinetics in the tumor microenvironment

por Sun, Clare, Wiestner, Adrian
Publicado 2017

Harnessing the Effects of BTKi on T Cells for Effective Immunotherapy against CLL

por Mhibik, Maissa, Wiestner, Adrian, Sun, Clare
Publicado 2019

COVID-19 vaccines for patients with haematological conditions

por Sun, Clare, Pleyer, Christopher, Wiestner, Adrian
Publicado 2021

Novel Agents and Emerging Strategies for Targeting the B-Cell Receptor Pathway in CLL

por Efremov, Dimitar G., Wiestner, Adrian, Laurenti, Luca
Publicado 2012

Monoclonal antibody (mAb)-based cancer therapy: Is it time to reevaluate dosing strategies?

por Lindorfer, Margaret A., Wiestner, Adrian, Zent, Clive S., Taylor, Ronald P.
Publicado 2012

Vibrio-Sequins - dPCR-traceable DNA standards for quantitative genomics of Vibrio spp

por Flütsch, Sabrina, Wiestner, Fabian, Butticaz, Lisa, Moor, Dominik, Stölting, Kai N.
Publicado 2023

Targeting malignant B cells with an immunotoxin against ROR1

por Baskar, Sivasubramanian, Wiestner, Adrian, Wilson, Wyndham H., Pastan, Ira, Rader, Christoph
Publicado 2012

CLL-140 Booster and BTKi Interruption Improve Response to SARS-CoV-2 Vaccine in Patients With CLL

por Bryer, Emily, Paul, Shira, Chen, Jonathan, Pleyer, Christopher, Wiestner, Adrian, Sun, Clare
Publicado 2022

Poster: CLL-140 Booster and BTKi Interruption Improve Response to SARS-CoV-2 Vaccine in Patients With CLL

por Bryer, Emily, Paul, Shira, Chen, Jonathan, Pleyer, Christopher, Wiestner, Adrian, Sun, Clare
Publicado 2022

Booster and Btki Interruption Improve Response to Sars-Cov-2 Vaccine in Patients with CLL

por Bryer, Emily, Paul, Shira, Chen, Jonathan, Pleyer, Christopher, Wiestner, Adrian, Sun, Clare
Publicado 2022

Identification of Therapeutic Candidates for Chronic Lymphocytic Leukemia from a Library of Approved Drugs

por Shen, Min, Zhang, Yaqin, Saba, Nakhle, Austin, Christopher P., Wiestner, Adrian, Auld, Douglas S.
Publicado 2013

Correction: Identification of Therapeutic Candidates for Chronic Lymphocytic Leukemia from a Library of Approved Drugs

por Shen, Min, Zhang, Yaqin, Saba, Nakhle, Austin, Christopher P., Wiestner, Adrian, Auld, Douglas S.
Publicado 2013

Fostamatinib inhibits B-cell receptor signaling, cellular activation and tumor proliferation in patients with relapsed and refractory chronic lymphocytic leukemia

por Herman, SEM, Barr, PM, McAuley, EM, Liu, D, Wiestner, A, Friedberg, JW
Publicado 2013

P1303: POTENTIATING ANTI-CD20 MONOCLONAL ANTIBODY THERAPY BY TARGETING COMPLEMENT C3 ACTIVATION FRAGMENTS COVALENTLY DEPOSITED ON LYMPHOMA CELLS

por Wiestner, A., Baskar, S., Peng, H., Gaglione, E., Lindorfer, M., Taylor, R., Rader, C.
Publicado 2022

Therapeutic Potential and Challenges of Targeting Receptor Tyrosine Kinase ROR1 with Monoclonal Antibodies in B-Cell Malignancies

por Yang, Jiahui, Baskar, Sivasubramanian, Kwong, Ka Yin, Kennedy, Michael G., Wiestner, Adrian, Rader, Christoph
Publicado 2011

Monoclonal antibodies targeting cell surface deposited complement fragment C3d potentiate cancer immunotherapy and eliminate antigen loss variants

por Skarzynski, Martin, Lindorfer, Margeret, Butera, Vicent, Vire, Berengere, Farooqui, Mohammed, Rader, Christoph, Taylor, Ronald, Wiestner, Adrian
Publicado 2015

Using high-sensitivity sequencing for the detection of mutations in BTK and PLCγ2 genes in cellular and cell-free DNA and correlation with progression in patients treated with BTK...

por Albitar, Adam, Ma, Wanlong, DeDios, Ivan, Estella, Jeffrey, Ahn, Inhye, Farooqui, Mohammed, Wiestner, Adrian, Albitar, Maher
Publicado 2017